HOME >> MEDICINE >> NEWS
Targeted nanoparticles incorporating siRNA offer promise for cancer treatment

The use of targeted nanoparticles offers promising techniques for cancer treatment. Researchers in the laboratory of Mark E. Davis at the California Institute of Technology have been using small interfering RNA (siRNA), sometimes known as silencing RNA, to "silence" specific genes that are implicated in certain malignancies. One of the primary challenges associated with this type of therapy is delivering the therapeutic agent into the body and then to the tumor in a safe and effective manner. By using targeted nanoparticles, researchers have demonstrated that systemically delivered siRNA can slow the growth of tumors in mice without eliciting the toxicities often associated with cancer therapies. The results of this research are being presented this week at the NSTI Nanotech 2007 Conference in Santa Clara, CA.

The Caltech researchers have incorporated siRNA into nanoparticles that are formed completely by self-assembly, characterized the behavior of these nanoparticles and studied their safety and efficacy in mice.

Using extensive physicochemical and biological characterization, the investigators are able to estimate the composition of individual nanoparticles and to correlate the nanoparticle structure with its biological function. This quantitative approach provides unique insights into the design of more effective nanoparticle carriers.

According to the lead author of the study, Derek W. Bartlett, "Safe and effective delivery remains perhaps the greatest impediment to the clinical realization of small interfering RNA (siRNA) in cancer therapy. Formation of siRNA nanoparticles using cyclodextrin-containing polycations is one of the most promising strategies for systemic siRNA delivery, and such nanoparticles are expected to enter Phase I clinical trials by late 2007. Our most recent work examines the impact of various dosing schedules and surface modifications on the efficacy of these siRNA nanoparticles in preclinical cancer mode
'"/>

Contact: Jami Walker
Jami.Walker@elsevier.com
314-579-3342
Elsevier Health Sciences
20-May-2007


Page: 1 2

Related medicine news :

1. Targeted, oral agent Enzastaurin shows favorable results
2. Targeted initiatives can encourage people to walk more
3. Targeted cancer drugs may work by disrupting balance of cellular signals
4. Targeted melanoma education of high risk groups improves screening
5. Targeted lymph node examination improves staging of colon cancer
6. Targeted therapy shows significant benefits over standard treatment for advanced kidney cancer
7. Targeted cancer drug combined with low-dose chemotherapy shrinks tumors, slows ovarian cancer
8. U-M researchers use nanoparticles to target brain cancer
9. Electric jolt triggers release of biomolecules, nanoparticles
10. Beyond the hype and the scare stories, how safe are nanoparticles?
11. MIT nanoparticles may help detect, treat tumors

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/3/2020)... Fla. (PRWEB) , ... September 03, 2020 , ... ... announced it is sponsoring the American Foundation for Suicide Prevention’s (AFSP) annual signature ... a million people across hundreds of U.S. cities to raise awareness of suicide ...
(Date:9/3/2020)... , ... September 03, 2020 , ... ... memory impairment, has announced the Best Memory Care Facilities in Louisville, KY. The ... features and amenities. , According to the Alzheimer’s Association , 5.6 ...
(Date:9/1/2020)... (PRWEB) , ... September 01, 2020 , ... ... a new practice in Glendale. While the office will be the first ... breast augmentation, tummy tucks, buttock augmentation (Brazilian butt lift), as well as rhinoplasty, ...
(Date:9/1/2020)... , ... September 01, 2020 , ... As fall and ... the Cohn Health Institute has taken this time to expand and grow ... its 30th Anniversary, the Cohn Health Institute will be relaunching its brand new website, ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... exclusively to funding innovative lymphoma research and serving the lymphoma community through a ... the 10th Anniversary of Blood Cancer Awareness Month (BCAM) and its international ...
Breaking Medicine News(10 mins):
(Date:8/27/2020)... ... August 27, 2020 , ... InfoMC, a leading provider ... of their 2020 System and Organizational Controls (SOC) 1® Type 2 and SOC ... compliance assessment. These achievements reflect their long-standing commitment to privacy, security, and risk ...
(Date:8/27/2020)... N.C. (PRWEB) , ... August 27, 2020 , ... Bleep ... football player and sleep apnea patient, is the company’s new spokesperson. , “In my ... football field. So, when I found the Bleep DreamPort it was a Bleeping no ...
(Date:8/27/2020)... (PRWEB) , ... August 27, 2020 , ... The ... conclusion of its fundraising initiative for Feeding San Diego with a press ... The GHT Companies presents the final check of $5,000.00+ representing an overall donation result ...
Breaking Medicine Technology:
Cached News: